Greystone Financial Group »

Vertex Pharmaceuticals Incorporated shares owned by Greystone Financial Group

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Greystone Financial Group from 13F filings

Historical chart of Greystone Financial Group investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Greystone Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Greystone Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $520k 1.1k 465.08
2024-06-30 $420k 895 468.72

More positions owned by Greystone Financial Group

Vanguard Bd Index Fds Long Term Bond (BLV)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Ishares Tr Jpmorgan Usd Emg (EMB)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Apple (AAPL)
Broadcom (AVGO)
Lockheed Martin Corporation (LMT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Microsoft Corporation (MSFT)
Wal-Mart Stores (WMT)
American Express Company (AXP)
Lowe's Companies (LOW)
JPMorgan Chase & Co. (JPM)
Sempra Energy (SRE)

View all positions for Greystone Financial Group

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates
Amundi
Morgan Stanley
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated